Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1N31
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,651
Award facts
- Contract value 100% obligated
- $35,650.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,650.81 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfilled this requirement as a child delivery order under its broader relationship with the federal government's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support, enabling the contractor to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The contract demonstrates AmerisourceBergen's capability to fulfill federal medical procurement requirements through open competition across multiple therapeutic domains, including specialty diabetes medications such as Ozempic.
Quick answers
Who was awarded contract SPE2DR26F1N31?
SPE2DR26F1N31 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F1N31 worth?
The government has obligated $35,651 on SPE2DR26F1N31.
Is contract SPE2DR26F1N31 an order under another contract?
Yes. SPE2DR26F1N31 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1N31 competed?
The extent of competition for SPE2DR26F1N31 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award